GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zai Lab Ltd (STU:1ZLB) » Definitions » Additional Paid-In Capital

Zai Lab (STU:1ZLB) Additional Paid-In Capital : €3,037.5 Mil(As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is Zai Lab Additional Paid-In Capital?


Zai Lab's quarterly additional paid-in capital increased from Sep. 2024 (€2,731.5 Mil) to Dec. 2024 (€3,117.4 Mil) but then stayed the same from Dec. 2024 (€3,117.4 Mil) to Mar. 2025 (€3,037.5 Mil).

Zai Lab's annual additional paid-in capital declined from Dec. 2022 (€2,731.1 Mil) to Dec. 2023 (€2,728.4 Mil) but then increased from Dec. 2023 (€2,728.4 Mil) to Dec. 2024 (€3,117.4 Mil).


Zai Lab Additional Paid-In Capital Historical Data

The historical data trend for Zai Lab's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zai Lab Additional Paid-In Capital Chart

Zai Lab Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,559.72 2,500.96 2,731.11 2,728.35 3,117.40

Zai Lab Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,753.82 2,798.12 2,731.50 3,117.40 3,037.52

Zai Lab Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Zai Lab Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Zai Lab's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Zai Lab Business Description

Industry
Traded in Other Exchanges
Address
4560 Jinke Road, Jinchuang Plaza, Building 1, 4th Floor, Pudong, Shanghai, CHN, 201210
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

Zai Lab Headlines

No Headlines